2 citations
,
January 2016 in “UvA-DARE (University of Amsterdam)” This review explores the unclear rationale behind excluding medical treatment methods from patentability and the complexities of allowing medical indication patents, offering potential solutions but reporting no new results.
In this study, personalized PRP therapy significantly increased hair density and diameter in a patient with androgenetic alopecia, highlighting its potential benefit but emphasizing the need for broader clinical trials.
In this study, researchers assessed the stability of various formulations in the TrichoConcept™ line for customized alopecia treatment. They found that the combinations remained stable from 14 to 180 days, supporting the use of these vehicles for enhancing therapeutic outcomes in hair loss treatments.
February 2025 in “Brazilian Journal of Hair Health” This case study found that a multimodal treatment approach effectively improved hair density and scalp coverage in a patient with androgenetic alopecia, with no reported adverse effects.
December 2021 in “Vestnik Rossiĭskoĭ akademii meditsinskikh nauk / Rossiĭskaia akademiia meditsinskikh nauk” In this study, personalized treatment of folic acid and vitamin E deficiencies improved hair parameters in AGA patients, while Se supplementation might be unnecessary.